{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:15:58Z","timestamp":1784279758446,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK123704"],"award-info":[{"award-number":["P30 DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK123704"],"award-info":[{"award-number":["P30 DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM 130457"],"award-info":[{"award-number":["P20 GM 130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001450"],"award-info":[{"award-number":["UL1 TR001450"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10620-025-08936-w","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:16:00Z","timestamp":1742314560000},"page":"2178-2185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial Differences in Liver Fibrosis Burden"],"prefix":"10.1007","volume":"70","author":[{"given":"Michael L.","family":"Attanasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Gregoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"8936_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","volume":"36","author":"A Khalifa","year":"2020","unstructured":"Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol 2020;36:184\u2013191.","journal-title":"Curr Opin Gastroenterol"},{"key":"8936_CR2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver D. Liver biopsy. Hepatology 2009;49:1017\u20131044.","journal-title":"Liver biopsy. Hepatology"},{"key":"8936_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000843.","author":"RK Sterling","year":"2024","unstructured":"Sterling RK, Duarte-Rojo A, Patel K, Asrani SK, Alsawas M, Dranoff JA et al. AASLD practice guideline on imaging-based non-invasive liver disease assessments of hepatic fibrosis and steatosis. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000843.","journal-title":"Hepatology"},{"key":"8936_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000845.","author":"RK Sterling","year":"2024","unstructured":"Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA et al. AASLD Practice Guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000845.","journal-title":"Hepatology"},{"key":"8936_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000842.","author":"K Patel","year":"2024","unstructured":"Patel K, Asrani SK, Fiel MI, Levine D, Leung DH, Duarte-Rojo A et al. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000842.","journal-title":"Hepatology"},{"key":"8936_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:198-210 e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8936_CR7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MEG.0000000000001735","volume":"33","author":"SK Satapathy","year":"2021","unstructured":"Satapathy SK, Marella HK, Heda RP, Ganguli S, Kirthi Reddy Y, Podila PSB et al. African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians. Eur J Gastroenterol Hepatol 2021;33:388\u2013398.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8936_CR8","first-page":"1613","volume":"98","author":"SA Giday","year":"2006","unstructured":"Giday SA, Ashiny Z, Naab T, Smoot D, Banks A. Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients. J Natl Med Assoc 2006;98:1613\u20131615.","journal-title":"J Natl Med Assoc"},{"key":"8936_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.soard.2004.12.006","volume":"1","author":"SF Solga","year":"2005","unstructured":"Solga SF, Clark JM, Alkhuraishi AR, Torbenson M, Tabesh A, Schweitzer M et al. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis 2005;1:6\u201311.","journal-title":"Surg Obes Relat Dis"},{"key":"8936_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","volume":"55","author":"K Bambha","year":"2012","unstructured":"Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012;55:769\u2013780.","journal-title":"Hepatology"},{"key":"8936_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2009.08.009","volume":"8","author":"ER Kallwitz","year":"2010","unstructured":"Kallwitz ER, Layden-Almer J, Dhamija M, Berkes J, Guzman G, Lepe R et al. Ethnicity and body mass index are associated with hepatitis C presentation and progression. Clin Gastroenterol Hepatol 2010;8:72\u201378.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8936_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ajg.2008.12","volume":"104","author":"ER Kallwitz","year":"2009","unstructured":"Kallwitz ER, Guzman G, TenCate V, Vitello J, Layden-Almer J, Berkes J et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 2009;104:64\u201369.","journal-title":"Am J Gastroenterol"},{"key":"8936_CR13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387\u20131395.","journal-title":"Hepatology"},{"key":"8936_CR14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.22726","volume":"49","author":"R Guerrero","year":"2009","unstructured":"Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009;49:791\u2013801.","journal-title":"Hepatology"},{"key":"8936_CR15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1572-0241.2002.05795.x","volume":"97","author":"SH Caldwell","year":"2002","unstructured":"Caldwell SH, Harris DM, Patrie JT, Hespenheide EE. Is NASH underdiagnosed among African Americans? Am J Gastroenterol 2002;97:1496\u20131500.","journal-title":"Am J Gastroenterol"},{"key":"8936_CR16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.metabol.2012.08.005","volume":"62","author":"ZM Younossi","year":"2013","unstructured":"Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with nonalcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2013;62:352\u2013360.","journal-title":"Metabolism"},{"key":"8936_CR17","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1542\/peds.2004-1832","volume":"115","author":"JB Schwimmer","year":"2005","unstructured":"Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005;115:e561\u2013e565.","journal-title":"Pediatrics"},{"key":"8936_CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","volume":"41","author":"SR Weston","year":"2005","unstructured":"Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005;41:372\u2013379.","journal-title":"Hepatology"},{"key":"8936_CR19","doi-asserted-by":"crossref","unstructured":"Flanagan BE, Gregory EW, Fallisey EJ, Heitgerd JL, Lewis B. A social vulnerability index for disaster management. Journal of Homeland Security and Emergency Management. 2011; 8.","DOI":"10.2202\/1547-7355.1792"},{"key":"8936_CR20","unstructured":"Registry CfDCAfTSaD. CDC\/ATSDR Social vulnerability index. Agency for toxic substances and disease registry; 2024."},{"key":"8936_CR21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313\u20131321.","journal-title":"Hepatology"},{"key":"8936_CR22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","volume":"19","author":"KP Batts","year":"1995","unstructured":"Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409\u20131417.","journal-title":"Am J Surg Pathol"},{"key":"8936_CR23","volume-title":"GeneReviews ((R))","author":"JK Stoller","year":"1993","unstructured":"Stoller JK, Hupertz V, Aboussouan LS et al. Alpha-1 antitrypsin deficiency. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., eds. Seattle (WA); 1993."},{"key":"8936_CR24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67:1560\u20131599.","journal-title":"Hepatology"},{"key":"8936_CR25","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V, Panel A-IHG. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023."},{"key":"8936_CR26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases. Hepatology 2020;72:671\u2013722.","journal-title":"Hepatology"},{"key":"8936_CR27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929\u2013938.","journal-title":"J Hepatol"},{"key":"8936_CR28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology 2020;71:306\u2013333.","journal-title":"Hepatology"},{"key":"8936_CR29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cld.1129","volume":"17","author":"M Bertha","year":"2021","unstructured":"Bertha M, Choi G, Mellinger J. Diagnosis and treatment of alcohol-associated liver disease: A patient-friendly summary of the 2019 AASLD guidelines. Clin Liver Dis (Hoboken) 2021;17:418\u2013423.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"8936_CR30","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77:1797\u20131835.","journal-title":"Hepatology"},{"key":"8936_CR31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cld.1216","volume":"19","author":"R Bahirwani","year":"2022","unstructured":"Bahirwani R, Griffin C. The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines. Clin Liver Dis (Hoboken) 2022;19:222\u2013226.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"8936_CR32","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","volume":"20","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol 2014;20:15539\u201315548.","journal-title":"World J Gastroenterol"},{"key":"8936_CR33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","volume":"65","author":"GT Brown","year":"2016","unstructured":"Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2016;65:1080\u20131086.","journal-title":"Metabolism"},{"key":"8936_CR34","first-page":"9026","volume":"20","author":"IL Nalbantoglu","year":"2014","unstructured":"Nalbantoglu IL, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol 2014;20:9026\u20139037.","journal-title":"World J Gastroenterol"},{"key":"8936_CR35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012;56:1751\u20131759.","journal-title":"Hepatology"},{"key":"8936_CR36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.hepres.2005.09.018","volume":"33","author":"T Fukusato","year":"2005","unstructured":"Fukusato T, Fukushima J, Shiga J, Takahashi Y, Nakano T, Maeyama S et al. Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. Hepatol Res 2005;33:122\u2013127.","journal-title":"Hepatol Res"},{"key":"8936_CR37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/apt.15503","volume":"50","author":"RK Pai","year":"2019","unstructured":"Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA et al. Standardising the interpretation of liver biopsies in nonalcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther 2019;50:1100\u20131111.","journal-title":"Aliment Pharmacol Ther"},{"key":"8936_CR38","first-page":"560","volume":"11","author":"ZM Younossi","year":"1998","unstructured":"Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998;11:560\u2013565.","journal-title":"Mod Pathol"},{"key":"8936_CR39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","volume":"54","author":"BR Bacon","year":"2011","unstructured":"Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. American association for the study of liver D. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American association for the study of liver diseases. Hepatology 2011;54:328\u2013343.","journal-title":"Hepatology"},{"key":"8936_CR40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 practice guidance from the american association for the study of liver diseases. Hepatology 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"8936_CR41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arrive L, Bergquist A, Deneau M, Forman L, Ilyas SI et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023;77:659\u2013702.","journal-title":"Hepatology"},{"key":"8936_CR42","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","volume":"77","author":"RJ Fontana","year":"2023","unstructured":"Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology 2023;77:1036\u20131065.","journal-title":"Hepatology"},{"key":"8936_CR43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009;2:231\u2013237.","journal-title":"Dis Model Mech"},{"key":"8936_CR44","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement. Circulation 2005;112:2735\u20132752.","journal-title":"Circulation"},{"key":"8936_CR45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2008.08.006","volume":"6","author":"NA Terrault","year":"2008","unstructured":"Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ et al. Fibrosis progression in African americans and caucasian americans with chronic hepatitis C. Clin Gastroenterol Hepatol 2008;6:1403\u20131411.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8936_CR46","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/j.1572-0241.2001.04050.x","volume":"96","author":"M Bonacini","year":"2001","unstructured":"Bonacini M, Groshen MD, Yu MC, Govindarajan S, Lindsay KL. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001;96:2438\u20132441.","journal-title":"Am J Gastroenterol"},{"key":"8936_CR47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1542-3565(04)00162-4","volume":"2","author":"K Crosse","year":"2004","unstructured":"Crosse K, Umeadi OG, Anania FA, Laurin J, Papadimitriou J, Drachenberg C et al. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol 2004;2:463\u2013468.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8936_CR48","doi-asserted-by":"crossref","unstructured":"Gordon SC, Lamerato LE, Rupp LB, Holmberg SD, Moorman AC, Spradling PR, et al. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study. Am J Gastroenterol. 2015;110:1169\u201377; quiz 78.","DOI":"10.1038\/ajg.2015.203"},{"key":"8936_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10620-011-1908-3","volume":"57","author":"M Kohla","year":"2012","unstructured":"Kohla M, Iwata S, Ea R, Keyhan S, Taylor R, Yu MC et al. Histological versus clinical cirrhosis in chronic hepatitis C: does race\/ethnicity really matter? Dig Dis Sci 2012;57:771\u2013776. https:\/\/doi.org\/10.1007\/s10620-011-1908-3.","journal-title":"Dig Dis Sci"},{"key":"8936_CR50","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ajg.2014.214","volume":"109","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Kramer J, Duan Z, Kanwal F. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol 2014;109:1427\u20131435.","journal-title":"Am J Gastroenterol"},{"key":"8936_CR51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1572-0241.2002.05555.x","volume":"97","author":"TE Wiley","year":"2002","unstructured":"Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol 2002;97:700\u2013706.","journal-title":"Am J Gastroenterol"},{"key":"8936_CR52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12072-008-9086-x","volume":"2","author":"FA Siddiqui","year":"2008","unstructured":"Siddiqui FA, Ehrinpreis MN, Janisse J, Dhar R, May E, Mutchnick MG. Demographics of a large cohort of urban chronic hepatitis C patients. Hepatol Int 2008;2:376\u2013381.","journal-title":"Hepatol Int"},{"key":"8936_CR53","first-page":"787","volume":"30","author":"KR Reddy","year":"1999","unstructured":"Reddy KR, Hoofnagle JH, Tong MJ, Lee WM, Pockros P, Heathcote EJ et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology 1999;30:787\u2013793.","journal-title":"Consensus Interferon Study Group. Hepatology"},{"key":"8936_CR54","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413\u20131419.","journal-title":"Gastroenterology"},{"key":"8936_CR55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","volume":"341","author":"MJ Alter","year":"1999","unstructured":"Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556\u2013562.","journal-title":"N Engl J Med"},{"key":"8936_CR56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461\u20131465.","journal-title":"Nat Genet"},{"key":"8936_CR57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1478-3231.2010.02444.x","volume":"31","author":"LE Wagenknecht","year":"2011","unstructured":"Wagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, Ziegler J et al. Association of PNPLA3 with nonalcoholic fatty liver disease in a minority cohort: the insulin resistance atherosclerosis family study. Liver Int 2011;31:412\u2013416.","journal-title":"Liver Int"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08936-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:48:43Z","timestamp":1750668523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08936-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["8936"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08936-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors certify that we have no financial arrangements (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, research support, honoraria) with a company whose product figures prominently in this manuscript or with a company making a competing product.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Don C. Rockey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor of the article"}}]}}